| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.65B | $ 5.15B | $ 4.69B | $ 4.22B | $ 3.58B |
| Gross Profit | $ 3.46B | $ 3.05B | $ 2.66B | $ 2.36B | $ 2.02B |
| Operating Income | $ 1.89B | $ 1.69B | $ 1.32B | $ 1.13B | $ 1.00B |
| EBITDA | $ 2.15B | $ 1.91B | $ 1.53B | $ 1.36B | $ 1.18B |
| Net Income | $ 1.52B | $ 1.40B | $ 1.02B | $ 897.56M | $ 779.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.47B | $ 1.21B | $ 238.36M | $ 227.89M | $ 273.71M |
| Total Assets | $ 8.97B | $ 8.17B | $ 6.87B | $ 6.75B | $ 5.10B |
| Total Debt | $ 825.92M | $ 851.81M | $ 873.93M | $ 1.58B | $ 917.55M |
| Net Debt | $ -643.32M | $ -357.64M | $ 635.57M | $ 1.35B | $ 643.84M |
| Total Liabilities | $ 2.38B | $ 2.21B | $ 2.01B | $ 2.62B | $ 1.74B |
| Stockholders' Equity | $ 6.59B | $ 5.97B | $ 4.86B | $ 4.13B | $ 3.36B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.65B | $ 1.66B | $ 1.29B | $ 559.30M | $ 195.11M |
| Operating Cash Flow | $ 1.81B | $ 1.75B | $ 1.40B | $ 693.30M | $ 351.15M |
| Investing Cash Flow | $ -545.20M | $ -200.04M | $ -269.78M | $ -1.16B | $ -229.92M |
| Financing Cash Flow | $ -1.01B | $ -606.25M | $ -1.12B | $ 422.87M | $ -128.36M |
Resmed (CH:RME)
:RME
